Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cadps | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Cadps (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CADPS mRNA | CTD | PMID:22206623 | Cadps | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Cadps (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of CADPS mRNA | CTD | PMID:22206623 | Cadps | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CADPS mRNA | CTD | PMID:16984957 | Cadps | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Cadps (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of CADPS mRNA | CTD | PMID:31388691 | Cadps | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CADPS mRNA | CTD | PMID:20959002 | Cadps | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CADPS mRNA | CTD | PMID:32109520 | Cadps | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cadps (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CADPS mRNA | CTD | PMID:24680724 | Cadps | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of CADPS mRNA | CTD | PMID:21346803 | Cadps | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CADPS mRNA | CTD | PMID:16984957 | Cadps | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CADPS mRNA | CTD | PMID:20959002 | Cadps | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of CADPS mRNA | CTD | PMID:30616060 | Cadps | Rat | 4-hydroxynon-2-enal | increases expression | ISO | Cadps (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of CADPS mRNA | CTD | PMID:19191707 | Cadps | Rat | aflatoxin B1 | decreases methylation | ISO | CADPS (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CADPS gene | CTD | PMID:27153756 | Cadps | Rat | Aflatoxin B2 alpha | increases methylation | ISO | CADPS (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of CADPS intron | CTD | PMID:30157460 | Cadps | Rat | all-trans-retinoic acid | increases expression | ISO | CADPS (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CADPS mRNA | CTD | PMID:21934132|PMID:23724009 | Cadps | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CADPS mRNA | CTD | PMID:35163327 | Cadps | Rat | arsenite(3-) | increases methylation | ISO | CADPS (Homo sapiens) | 6480464 | arsenite results in increased methylation of CADPS promoter | CTD | PMID:23974009 | Cadps | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of CADPS gene | CTD | PMID:35440735 | Cadps | Rat | benzo[a]pyrene | affects methylation | ISO | CADPS (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CADPS promoter | CTD | PMID:27901495 | Cadps | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of CADPS mRNA | CTD | PMID:31163220 | Cadps | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ... | CTD | PMID:31199487 | Cadps | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CADPS mRNA | CTD | PMID:25181051|PMID:30816183|PMID:34947998 | Cadps | Rat | bisphenol A | decreases expression | ISO | Cadps (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CADPS mRNA | CTD | PMID:32156529 | Cadps | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CADPS gene | CTD | PMID:28505145 | Cadps | Rat | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ... | CTD | PMID:31199487 | Cadps | Rat | cadmium atom | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | Cadmium results in decreased expression of CADPS mRNA | CTD | PMID:24376830 | Cadps | Rat | choline | multiple interactions | ISO | Cadps (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Cadps | Rat | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of CADPS mRNA | CTD | PMID:30556269 | Cadps | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of CADPS mRNA | CTD | PMID:30556269 | Cadps | Rat | DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of CADPS mRNA | CTD | PMID:30207508 | Cadps | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CADPS mRNA | CTD | PMID:21266533 | Cadps | Rat | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ... | CTD | PMID:31199487 | Cadps | Rat | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ... | CTD | PMID:31199487 | Cadps | Rat | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ... | CTD | PMID:31199487 | Cadps | Rat | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ... | CTD | PMID:31199487 | Cadps | Rat | dorsomorphin | multiple interactions | ISO | CADPS (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Cadps | Rat | ethanol | affects splicing | ISO | Cadps (Mus musculus) | 6480464 | Ethanol affects the splicing of CADPS mRNA | CTD | PMID:30319688 | Cadps | Rat | fenamidone | decreases expression | ISO | Cadps (Mus musculus) | 6480464 | fenamidone results in decreased expression of CADPS mRNA | CTD | PMID:27029645 | Cadps | Rat | folic acid | multiple interactions | ISO | Cadps (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CADPS mRNA; [Methionine deficiency co-treated more ... | CTD | PMID:20938992|PMID:22206623 | Cadps | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CADPS mRNA | CTD | PMID:25539665 | Cadps | Rat | ivermectin | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CADPS protein | CTD | PMID:32959892 | Cadps | Rat | L-methionine | multiple interactions | ISO | Cadps (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Cadps | Rat | lead(0) | affects splicing | ISO | CADPS (Homo sapiens) | 6480464 | Lead affects the splicing of CADPS mRNA | CTD | PMID:28903495 | Cadps | Rat | methylmercury chloride | increases expression | ISO | CADPS (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CADPS mRNA | CTD | PMID:23179753 | Cadps | Rat | methylmercury chloride | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CADPS mRNA | CTD | PMID:28001369 | Cadps | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of CADPS gene | CTD | PMID:33148267 | Cadps | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CADPS mRNA; [Diethylnitrosamine co-treated with Phenobarbital] more ... | CTD | PMID:25374375 | Cadps | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CADPS mRNA | CTD | PMID:35163327 | Cadps | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of CADPS gene | CTD | PMID:33148267 | Cadps | Rat | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CADPS mRNA; [Diethylnitrosamine co-treated with Phenobarbital] more ... | CTD | PMID:25374375 | Cadps | Rat | phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of CADPS mRNA | CTD | PMID:18158353 | Cadps | Rat | pirinixic acid | increases expression | ISO | Cadps (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CADPS mRNA | CTD | PMID:20813756 | Cadps | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CADPS mRNA | CTD | PMID:28374803 | Cadps | Rat | SB 431542 | multiple interactions | ISO | CADPS (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Cadps | Rat | sodium arsenite | decreases expression | ISO | Cadps (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CADPS mRNA | CTD | PMID:36209798 | Cadps | Rat | succimer | multiple interactions | ISO | Cadps (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CADPS mRNA | CTD | PMID:26378955 | Cadps | Rat | sunitinib | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CADPS mRNA | CTD | PMID:31533062 | Cadps | Rat | temozolomide | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of CADPS mRNA | CTD | PMID:31758290 | Cadps | Rat | testosterone | increases expression | ISO | Cadps (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of CADPS mRNA | CTD | PMID:33848595 | Cadps | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CADPS mRNA | CTD | PMID:31150632 | Cadps | Rat | titanium dioxide | increases methylation | ISO | Cadps (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of CADPS gene | CTD | PMID:35295148 | Cadps | Rat | titanium dioxide | decreases methylation | ISO | Cadps (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CADPS promoter | CTD | PMID:35295148 | Cadps | Rat | trichostatin A | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CADPS mRNA | CTD | PMID:24935251 | Cadps | Rat | trichostatin A | increases expression | ISO | CADPS (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CADPS mRNA | CTD | PMID:24935251|PMID:26272509 | Cadps | Rat | triclosan | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | Triclosan results in decreased expression of CADPS mRNA | CTD | PMID:30510588 | Cadps | Rat | valproic acid | decreases expression | ISO | CADPS (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CADPS mRNA | CTD | PMID:23179753|PMID:26272509|PMID:28001369 | Cadps | Rat | valproic acid | multiple interactions | ISO | CADPS (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Cadps | Rat | vorinostat | increases expression | ISO | CADPS (Homo sapiens) | 6480464 | vorinostat results in increased expression of CADPS mRNA | CTD | PMID:26272509 | Cadps | Rat | vorinostat | multiple interactions | ISO | CADPS (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cadps | Rat | zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of CADPS mRNA | CTD | PMID:17074742 | Cadps | Rat | zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of CADPS mRNA | CTD | PMID:17074742 | Cadps | Rat | zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of CADPS mRNA | CTD | PMID:17074742 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















